Search research articles
Contact Us
Filters
Showing results (51-60 of 62) with videos related to
Page
of 7
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 25, 2025
[<sup>18</sup>F]-Labeled Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Staging and Restaging Patients With Breast Cancer
David Groheux, Sofia C Vaz, Lioe-Fee de Geus-Oei, et al.
Cancer Cell
|
November 22, 2024
Mutation burden and anti-PD-1 outcomes are not universally associated with immune cell infiltration or lymphoid activation
David Hsiehchen, Andrew Elliott, Joanne Xiu, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 13, 2024
Joint EANM-SNMMI guideline on the role of 2-[<sup>18</sup>F]FDG PET/CT in no special type breast cancer : (endorsed by the ACR, ESSO, ESTRO, EUSOBI/ESR, and EUSOMA)
Sofia C Vaz, John Patrick Pilkington Woll, Fatima Cardoso, et al.
JCO Precision Oncology
|
April 28, 2025
Association of Androgen Receptor Expression With Tumor Immune Landscape and Treatment Outcomes of Patients With Breast Cancer
Priya Jayachandran, Sachin K Deshmukh, Sharon Wu, et al.
Nature Cancer
|
March 26, 2024
Tissue-specific thresholds of mutation burden associated with anti-PD-1/L1 therapy benefit and prognosis in microsatellite-stable cancers
Maishara Muquith, Magdalena Espinoza, Andrew Elliott, et al.
Expert Opinion on Pharmacotherapy
|
May 29, 2024
Emerging pharmacotherapy trends in preventing and managing oral mucositis induced by chemoradiotherapy and targeted agents
Margherita Gobbo, Jamie Joy, Helena Guedes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 20, 2020
Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Guideline Update
Neelima Denduluri, Mark R Somerfield, Mariana Chavez-MacGregor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 10, 2025
A Phase II Trial to Evaluate the Safety and Immunogenicity of Two Doses of a Folate Receptor Alpha Vaccine in Patients with Triple-Negative Breast Cancer
Keith L Knutson, Hala Abu-Fares, Patricia Keating, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 18, 2024
Abemaciclib Plus Fulvestrant in Advanced Breast Cancer After Progression on CDK4/6 Inhibition: Results From the Phase III postMONARCH Trial
Kevin Kalinsky, Giampaolo Bianchini, Erika Hamilton, et al.
The Journal of Clinical Investigation
|
January 14, 2025
TRAIL agonists rescue mice from radiation-induced lung, skin, or esophageal injury
Jillian Strandberg, Anna Louie, Seulki Lee, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 62) with videos related to
Sort By:
Page
of 7
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 25, 2025
[<sup>18</sup>F]-Labeled Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Staging and Restaging Patients With Breast Cancer
David Groheux, Sofia C Vaz, Lioe-Fee de Geus-Oei, et al.
Cancer Cell
|
November 22, 2024
Mutation burden and anti-PD-1 outcomes are not universally associated with immune cell infiltration or lymphoid activation
David Hsiehchen, Andrew Elliott, Joanne Xiu, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 13, 2024
Joint EANM-SNMMI guideline on the role of 2-[<sup>18</sup>F]FDG PET/CT in no special type breast cancer : (endorsed by the ACR, ESSO, ESTRO, EUSOBI/ESR, and EUSOMA)
Sofia C Vaz, John Patrick Pilkington Woll, Fatima Cardoso, et al.
JCO Precision Oncology
|
April 28, 2025
Association of Androgen Receptor Expression With Tumor Immune Landscape and Treatment Outcomes of Patients With Breast Cancer
Priya Jayachandran, Sachin K Deshmukh, Sharon Wu, et al.
Nature Cancer
|
March 26, 2024
Tissue-specific thresholds of mutation burden associated with anti-PD-1/L1 therapy benefit and prognosis in microsatellite-stable cancers
Maishara Muquith, Magdalena Espinoza, Andrew Elliott, et al.
Expert Opinion on Pharmacotherapy
|
May 29, 2024
Emerging pharmacotherapy trends in preventing and managing oral mucositis induced by chemoradiotherapy and targeted agents
Margherita Gobbo, Jamie Joy, Helena Guedes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 20, 2020
Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Guideline Update
Neelima Denduluri, Mark R Somerfield, Mariana Chavez-MacGregor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 10, 2025
A Phase II Trial to Evaluate the Safety and Immunogenicity of Two Doses of a Folate Receptor Alpha Vaccine in Patients with Triple-Negative Breast Cancer
Keith L Knutson, Hala Abu-Fares, Patricia Keating, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 18, 2024
Abemaciclib Plus Fulvestrant in Advanced Breast Cancer After Progression on CDK4/6 Inhibition: Results From the Phase III postMONARCH Trial
Kevin Kalinsky, Giampaolo Bianchini, Erika Hamilton, et al.
The Journal of Clinical Investigation
|
January 14, 2025
TRAIL agonists rescue mice from radiation-induced lung, skin, or esophageal injury
Jillian Strandberg, Anna Louie, Seulki Lee, et al.
Page
of 7